Related Experiment Video
Updated: May 7, 2026
Maintaining Aedes aegypti Mosquitoes Infected with Wolbachia
Published on: August 14, 2017
Wolbachia releases for dengue control: why the evidence supports a pause and independent re-evaluation
Osvaldo Marinotti1, Nitzan Paldi2, David Gorla3
1Department of Biology, Indiana University, Bloomington, IN, USA.
Background:
Aedes aegypti is the primary vector of dengue and other arboviruses whose global incidence continues to rise. In response, releases of Aedes aegypti infected with the wMel strain of Wolbachia pipientis have been promoted as a sustainable, transmission-blocking strategy to curb arboviral disease.
Objectives:
This study was undertaken to reassess the real-world performance of wMel-Wolbachia interventions, evaluate their epidemiological impact and durability under diverse field conditions.
Methods:
Evidence from peer-reviewed publications, program documentation, and routine surveillance systems in countries with large-scale Wolbachia deployments, including Brazil, Colombia, Vietnam, and Indonesia, was synthesised. Temporal patterns of dengue incidence, Wolbachia infection frequencies in mosquito populations, and contextual environmental and operational factors were examined using national and municipal datasets and official reports.
Results:
Across settings, wMel-Wolbachia releases have been associated with highly variable epidemiological outcomes, including areas where substantial dengue transmission has persisted or re-emerged after deployment. Field data have documented loss or marked decline of Wolbachia infection in local Aedes aegypti populations and dengue outbreaks within release zones. Limited access to underlying data is available for independent analyses. Theoretical and empirical evidence from vector-pathogen systems indicates that partial transmission blocking potentially imposes selection favouring more transmissible or virulent viral variants.
Conclusion:
Available evidence does not support unqualified scale-up of wMel-Wolbachia releases as a robust, long-term dengue control strategy across diverse ecological and operational contexts. A global pause on ongoing and planned deployments, alongside an independent, transparent, science-based re-evaluation of effectiveness, safety, and sustainability, is therefore warranted before further expansion.
Insights
Releases of Aedes aegypti mosquitoes with wMel-Wolbachia have shown variable dengue control results. Further evaluation is needed before widespread deployment of this arboviral disease strategy.
Area of Science:
- Medical Entomology
- Infectious Disease Epidemiology
- Vector-borne Disease Control
Background:
- Aedes aegypti mosquitoes transmit dengue and other arboviruses globally.
- Wolbachia pipientis infections in Aedes aegypti are used to reduce arboviral disease transmission.
Purpose of the Study:
- To reassess the real-world performance of wMel-Wolbachia interventions.
- To evaluate the epidemiological impact and durability of these interventions in diverse field conditions.
Main Methods:
- Synthesized evidence from peer-reviewed publications, program documentation, and surveillance systems in Brazil, Colombia, Vietnam, and Indonesia.
- Examined temporal dengue incidence, Wolbachia infection frequencies, and environmental/operational factors using national and municipal data.
Main Results:
- WMel-Wolbachia releases showed highly variable dengue control outcomes, with persistent or re-emergent transmission in some areas.
- Observed loss or decline of Wolbachia infection in mosquito populations and subsequent dengue outbreaks.
- Limited data accessibility hinders independent analysis; theoretical evidence suggests potential for selection of more virulent viral variants.
Conclusions:
- Current evidence does not support unqualified scale-up of wMel-Wolbachia releases for dengue control.
- A global pause on deployments is warranted for independent re-evaluation of effectiveness, safety, and sustainability.
